Flynn-Aird syndrome

Flynn-Aird syndrome is an extremely rare multisystem neurodegenerative disorder characterized by a combination of progressive neurological, ophthalmological, dermatological, and skeletal abnormalities. The condition was first described by Flynn and Aird in 1965 in a large family spanning multiple generations. Key clinical features include progressive bilateral cataracts, retinitis pigmentosa (progressive degeneration of the retina leading to vision loss), progressive sensorineural deafness, peripheral neuropathy, skin atrophy, skeletal abnormalities (including joint stiffness and bone cysts), dental caries, and epilepsy. Affected individuals may also develop progressive dementia and ataxia (impaired coordination) over time. The syndrome affects multiple body systems including the central and peripheral nervous systems, eyes, ears, skin, and musculoskeletal system. The progressive nature of the condition means that symptoms typically worsen over time, with neurological deterioration being a prominent feature. Some patients may also exhibit endocrine abnormalities. There is currently no specific cure or targeted treatment for Flynn-Aird syndrome. Management is supportive and symptomatic, focusing on addressing individual manifestations such as hearing aids for deafness, surgical intervention for cataracts, anticonvulsant medications for seizures, and physical therapy for neurological and musculoskeletal complications. A multidisciplinary approach involving ophthalmologists, neurologists, audiologists, dermatologists, and orthopedic specialists is recommended for comprehensive care. Due to the extreme rarity of this condition, clinical experience is very limited and largely based on the original family reports.

Common questions about Flynn-Aird syndrome